Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis

International Journal of Antimicrobial Agents

Volumn 17, Issue 2, 2001, Pages 109-113

  Jenney, Adam W J ^a   Lum, Gary ^a   Fisher, Dale A ^a   Currie, Bart J ^a,b  

^a ROYAL DARWIN HOSPITAL   (Australia)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

Burkholderia pseudomallei; Culture positive infections; Melioidosis study

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFTAZIDIME; CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; DOXYCYCLINE; IMIPENEM; MEROPENEM; PIPERACILLIN; TRIMETHOPRIM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; HUMAN; MAJOR CLINICAL STUDY; MELIOIDOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTI-BACTERIAL AGENTS; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; DOXYCYCLINE; DRUG RESISTANCE, MICROBIAL; HUMANS; IMIPENEM; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; THIENAMYCINS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TROPICAL CLIMATE;

EID: 0035142069     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00334-4     Document Type: Article

References (26)

1. Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand
2. Melioidosis: the tip of the iceberg?
3. Melioidosis: review and update
4. Tropical disease in the immunocompromised host: melioidosis and pythiosis
5. The epidemiology of melioidosis in Australia and Papua New Guinea
6. Medicine in tropical Australia
7. Evaluation of the E-test, a novel method of quantifying antimicrobial activity
8. In vitro susceptibilities of Pseudomonas pseudomallei to 27 antimicrobial agents
9. Comparison of imipenem and ceftazidime as therapy for severe melioidosis
10. The anti-microbial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment
11. Laboratory investigations of Australian isolates of ceftazidime resistant Pseudomonas pseudomallei
12. A comparison of chloramphenicol, trimethoprim-sulphamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis
13. Interactions in vitro between agents used to treat melioidosis
14. Halving the mortality of severe melioidosis by ceftazidime
15. Multicenter prospective randomised trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis
16. Comparative in vitro susceptibility of Burkholderia pseudomallei to cefpirome, ceftazidime and cefepime
17. Susceptibility of Pseudomonas pseudomallei to new beta-lactam and aminiglycoside antibiotics
18. Ceftazidime vs. Amoxicillin/clavulanate in the treatment of severe melioidosis
19. RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis
20. Intracellular survival of Burholderia pseudomallei
21. Burkholderia pseudomallei activates complement and is ingested but not killed by polymorphonuclear leukocytes
22. Oral fluoroquinolones for the maintenance treatment of melioidosis
23. Melioidosis; when in doubt leave quinolone alone!
24. A maintenance therapy of melioidosis with ciprofloxacin plus azithromycin compared with cotrimoxazole plus doxycycline: a preliminary study
25. In vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of Burkholderia pseudomallei